基于功能磁共振成像的径向体外冲击波治疗原发性痛经即时镇痛效果:随机安慰剂对照试验方案
治疗于月经48小时内进行,主要指标为McGill疼痛问卷简表与Cox月经症状量表,次要指标包括焦虑抑郁量表及功能磁共振脑区变化,旨在探索即刻疗效与神经镇痛机制。
要点
- 径向体外冲击波治疗原发性痛经的即时镇痛效果尚待随机对照试验验证。
- 试验采用假冲击波对照,主要结局为McGill疼痛问卷简表与Cox月经症状量表。
- 功能磁共振用于探索即刻神经镇痛机制与脑网络关联。
核心结论
- 该随机对照试验方案旨在探索径向体外冲击波对原发性痛经的即时疗效及脑功能变化。
研究设计与样本
- rESWT组在月经48小时内于6个腹部肌筋膜触发点接受一次治疗,假组同部位无能量输入。
关键数值与推荐
- 主要指标为McGill疼痛问卷简表与Cox月经症状量表。
- 次要指标包括Zung焦虑自评量表、抑郁自评量表及功能磁共振脑区变化。
- 结果在筛选期、基线、治疗前后评估,并检查不良事件。
临床怎么用
- 方案提出rESWT作为原发性痛经潜在非侵入性镇痛手段,但疗效需待试验结果确认。
局限性
- 本文为研究方案,尚未报告疗效与安全性结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary dysmenorrhoea (PDM) is defined as a series of pain-dominated symptoms during and after menstruation without organic lesions. Nonsteroidal anti-inflammatory drugs and oral contraceptives are usually recommended as first-line therapy for the clinical treatment of PDM, but their widespread long-term application is controversial. Radial extracorporeal shock wave therapy (rESWT) has been widely applied in musculoskeletal rehabilitation because of its secure and noninvasive characteristics and its confirmed effect in improving pain symptoms. This research seeks to explore the efficacy of rESWT for PDM and the changes in brain function of patients with PDM. METHODS: This clinical research will be a randomised, blind, sham-controlled trial. Thirty-six patients with PDM will be randomly divided into the rESWT group (n = 18) and the sham rESWT group (n = 18). In the rESWT group, treatment will be applied once within 48 h of menstruation at six abdominal myofascial trigger points. The sham rESWT group will receive sham shockwave therapy on the same sites but without energy input. Other dysmenorrhoea-related treatments in both groups will be limited. The main indicators include the short form of the McGill Pain Questionnaire and the Cox Menstrual Symptom Scale. The secondary indicators include the Zung Self-rating Anxiety Scale and Self-rating Depression Scale and functional magnetic resonance imaging (fMRI) changes in brain regions. Results will be evaluated at the screening, at baseline, and before and after treatment, and adverse treatments will be examined. Inter- and intragroup analyses will be performed. DISCUSSION: This randomised controlled study is designed to explore the immediate efficacy of rESWT for PDM. After rESWT treatment, PDM symptom tests and pain tests, as well as fMRI data, will be investigated for the potential connections between immediate neuroanalgesic mechanisms, which are associated with pain and brain networks. The main results will be used to assess the efficacy of rESWT, and secondary results will focus on improving the neurobiological understanding of disease treatment. TRIAL REGISTRATION: China Clinical Trial Register, ChiCTR1900020678. Registered on 13 January 2019.
引用
- Liu S, Wang L, Yang J, et al. Instant analgesic effect of radial extracorporeal shock wave therapy on primary dysmenorrhoea according to functional magnetic resonance imaging: study protocol for a randomised placebo-controlled trial. Trials. 2020. PMID: 32046753. doi:10.1186/s13063-020-4045-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。